Catalytic oligonucleotides targeting Egr-1 as potential inhibitors of in-stent restenosis

Annals of the New York Academy of Sciences

Volumn 947, Issue , 2001, Pages 412-415

  Khachigian, Levon M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Catalytic oligonucleotides; Early growth response factor I; Restenosis

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; OLIGONUCLEOTIDE;

CONFERENCE PAPER; CORONARY STENT; HUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROTEIN EXPRESSION; PROTEIN TARGETING; REGULATORY MECHANISM; RESTENOSIS;

EID: 0035683781     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03975.x     Document Type: Conference Paper

References (33)

1. Explosive growth of coronary angioplasty: Success story of a less than perfect procedure
2. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
3. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
4. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months
5. Lack of neointimal proliferation after implantation of Sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimentional intravascular ultrasound study
6. Clinical trials of vascular brachytherapy for in-stent restenosis
7. Histopathology of in-stent restenosis in patients with peripheral artery disease
8. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury
9. Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal
10. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury: A putative mechanism for autocrine growth
11. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
12. c-myc in vasculo-proliferative disease
13. Expression of NF-kappaB and IkappaB-alpha by aortic endothelium in an arterial injury model
14. Induction of ETS-1 in endothelial cells during reendothelialization after denuding injury
15. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery
16. Egr-1-induced endothelial gene expression: A common theme in vascular injury
17. Early growth response protein 1 (Egr-1): Prototype of a zinc-finger family of transcription factors
18. Catalytic DNA as therapeutic agents and molecular tools to dissect biological function
19. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis
20. Frontiers in interventional cardiology
21. Vascular smooth muscle cell proliferation and regrowth after injury in vitro is dependent upon NGFI-A/Egr-1
22. Egr-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2
23. A general purpose RNA-cleaving DNA enzyme
24. Sequence-specific cleavage of the HIV-1 coreceptor CCR5 gene by a hammer-head ribozyme and a DNA-enzyme: Inhibition of the coreceptor function by DNA-enzyme
25. Targeted cleavage of HIV-1 envelope gene by a DNA enzyme and inhibition of HIV-1 envelope-CD4 mediated cell fusion
26. Inhibition of infection of incoming HIV-1 virus by RNA-cleaving DNA enzyme
27. Sequence-specific cleavage of Huntingtin mRNA by catalytic DNA
28. Suppression of smooth muscle cell proliferation by a c-myc RNA-cleaving deoxyribozyme
29. Extremely high and specific activity of DNA enzymes in cells with a Philadelphia chromosome
30. Inhibition of bcr-abl oncogene by novel deoxyribozymes (DNAzymes)
31. DzyNA-PCR: Use of DNAzymes to detect and quantify nucleic acid sequences in a real-time fluorescent format
32. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth factor injury
33. Catalytic oligodeoxynucleotides define a critical regulatory role for early growth response factor-I in the porcine coronary artery model of in-stent restenosis